Back to Search
Start Over
T.04.5: COMPARISON OF SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE SHOWED NO DIFFERENCES IN IMMUNOGENICITY OR TREATMENT PERSISTENCE AT ONE YEAR.
- Source :
- Digestive & Liver Disease; 2024 Supplement 2, Vol. 56, pS239-S239, 1p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 15908658
- Volume :
- 56
- Database :
- Supplemental Index
- Journal :
- Digestive & Liver Disease
- Publication Type :
- Academic Journal
- Accession number :
- 176502733
- Full Text :
- https://doi.org/10.1016/S1590-8658(24)00592-9